Ignite Creation Date:
2024-05-05 @ 12:06 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00244985
Status:
COMPLETED
Last Update Posted:
2017-08-17
First Post:
2005-10-25
Brief Title:
Rituximab and Liposomal Doxorubicin in Treating Patients With Relapsed or Refractory Non-Hodgkins Lymphoma
Sponsor:
Roswell Park Cancer Institute
Organization:
Roswell Park Cancer Institute
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Lymphoma |
Keywords:
| Name | View |
|---|---|
| splenic marginal zone lymphoma | View |
| recurrent grade 1 follicular lymphoma | View |
| recurrent grade 2 follicular lymphoma | View |
| recurrent grade 3 follicular lymphoma | View |
| recurrent mantle cell lymphoma | View |
| recurrent small lymphocytic lymphoma | View |
| recurrent adult diffuse large cell lymphoma | View |
| recurrent adult diffuse mixed cell lymphoma | View |
| recurrent marginal zone lymphoma | View |
| extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue | View |
| nodal marginal zone B-cell lymphoma | View |